The human ,B-globin dominant control region (DCR) which flanks the multigene 3-globin locus directs high level, site of integration independent, copy number dependent expression on a linked human ,-globin gene in transgenic mice and stably transfected mouse erythroleukemia (MEL) cells. We have assayed each of the individual DNasel hypersensitve regions present in the full 15kb DCR for position independence and copy number dependence of a linked ,3-globin gene in transgenic mice. The results show that at least three of the individual DNasel hypersensitive site regions (sites 1, 2 and 3), though expressing at lower levels than the full DCR, are capable of position independent, copy number dependent expression. Site 2 alone directs the highest level of expression of the single site constructs, producing nearly 70% of the level of the full DCR. Sites 1 and 3 each provide 30% of the full activity. Deletion of either site 2 or 3 from the complete set significantly reduces the level of expression, but does not effect position independence or copy number dependence. This demonstrates that sites 2 and 3 are required for full expression and suggests that all the sites are required for the full expression of even a single gene from this multigene locus.
INTRODUCTION
The human (3-like globin genes are a family of five, closely linked, active genes arranged in the order of their developmental expression on the short arm of chromosome 11 (Fig. 1) . Progress in delineating and defining the function of cis-elements involved in transcriptional regulation of the human ,B-globin gene has been achieved through the use of transgenic mice and mouse erythroleukemia (MEL) cell model systems. Three tissue-specific regulatory regions, found within and flanking the gene, contain sufficient information for differentiation-and developmental-stage specific expression (1, 2, 3, 4) . These regions encompass the promoter and two downstream enhancer elements, located within the gene and in the 3' flanking region. A number of cis-acting elements within these regions have been identified which bind ubiquitous and/or erythroid-specific proteins (5, 6, 7) , the most notable being the erythroid factor NF-E1 (GF-1, Eryfl) which has been cloned from human (8) , mouse (9) and chicken (10) .
Human (-globin gene constructs which contain all these regions have been shown to result in tissue-and stage-specific expression. However, the level of expression of the exogenous gene is highly variable, not dependent on copy number, and occurs at a fraction of the level of its endogenous counterpart (1, 11, 12, 13) . These phenomena have been attributed to effects of the integration locus and suggested that insufficient sequence information was present for fully regulated, position independent expression. Our laboratory has shown that inclusion of the dominant control region (DCR), confers position independent, high level expression on a linked ,B-globin gene in MEL cells (14) and transgenic mice (15) . The DCR which is contained in 20kb upstream of the (3- globin cluster (Fig. la,b) consists of a series of four erythroid specific DNaseI hypersensitive regions designated 5' to 3', sites 1,2,3,4 (15) or IV, Im, II, I (16), or -18, -14.7, -10.9 and -6.1 (17) . Linkage of the four DNA fragments which span the individual hypersensitive sites into a micro DCR (Fig. lc) retains full functional capability, regardless of its orientation relative to the linked ,B-globin gene (18) . The DCR is also capable of inducing high level expression of a-globin (19, 20) , y-globin (21, 22) and heterologous genes (15, 17) .
It is important to point out that the DCR has been assayed in a number of expression systems with varying results, suggesting that the individual sites have different functional capabilities. Transient assays in K562 cells (23) (20, 25) .
In this paper we assess the activity of each of the individual DNaseI hypersensitive sites (sites 1-4) on a linked (3- (Fig. 2) .
Copy Number Determination
The copy number of non-mosaic transgenic fetuses was determined by Southern blot analysis of placental DNA as described above. The ,B-globin and NF-H specific bands in each lane of the autoradiograms were scanned with a laser densitometer and the ,3-globin signal was normalized with the value obtained from the NF-H specific band to obtain a relative copy number. These were arranged in a hierarchy from low to high transgene copy number and five DNA samples representing this range were selected. The copy numbers of these samples were then determined by a series of dilutions made with non-transgenic DNA to approximate the level of a single copy integrant. The signal obtained from the Southern blots of the diluted samples was compared to that of the single copy transgenic number 32 (based on end fragment analysis) and copy numbers were assigned. These values were then used as a scale in the estimation of copy numbers of transgenic fetuses in the hierarchy. Copy numbers ranged from single copy integrants to greater than 60 copies (Table I) .
Expression Analysis of the DCR Deletion Mutants Total RNA was isolated from 13.5 day transgenic fetal livers and analyzed by quantitative S1 nuclease protection assay with mixed probes for 5' human 4-globin and 5' mouse j3maj globin mRNAs (Fig. 3) . Total RNA from Hull MEL cells (32) and 13.5 day fetal liver RNA from a transgenic mouse containing three copies of the fulll microlocus (Fig. ic) were used as controls (18) . After autoradiography, individual bands were excised from the gel and Cerenkov counted in a scintillation counter. The expression of human 3-globin was calculated as a ratio of the endogenous mouse j3_maj globin and normalized per gene copy of the exogenous gene (Table 1) .
Single Site Constructs Transgenic mice containing single hypersensitive site constructs express significantly higher levels of 0-globin RNA than those which contain no DCR hypersensitive sites (Fig. 3 and Table  I ). Site 2 expresses highest at nearly 70% of the level of a single endogenous 03maj globin gene. Site 1 and site 3 confer approximately 30% of the level. Site 4 transgenics express the lowest levels of human 13-globin of the single hypersensitive site constructs at 4-10%. These results differ from those obtained in stably transformed MEL cell populations in which site 2 and site 3 provide 60 and 40% respectively, and site 1 and site 4 showed low levels of expression (<10%, 24) . Clearly, in transgenic mice, site 1 is as capable as site 3 in producing high levels of f-globin RNA. A distinctive feature of the minilocus (Fig. Ib) and microlocus (Fig. Ic) 
DISCUSSION
We have previously shown that the full 4-globin minilocus and microlocus provide position independent, high level expression of human 3-globin in transgenic mice (15, 18) . The results presented here demonstrate that the function of position independence and copy number dependence can be provided by the individual sites 1, 2 and 3, and shows that sites 2 and 3 are required for full expression. This suggests that multiple sites act synergistically and are needed for the expression of each individual gene. Consequently, the presence of a number of DCR elements is not related to the fact that it is a multigene family per se. Our results in the analysis of single site constructs differ from those obtained in stably transformed MEL cell populations (24) and transient CAT assays in K562 cells (22) or MEL cells (C-H. Chang and P. Dierks, pers. comm.). In transient assays, only site 3 was found to have significant enhancing activity. The results from stable populations of MEL cells showed that sites 2 and 3 had the strongest activating function. In transgenic mice we show that site 1 has similar transcriptional activating capacity as site 3 and that site 2 alone produces the highest levels of expression, approximately two-fold greater than 1 or 3 alone. The fact that sites 1, 2 and 3 are each capable of conferring position independent, copy number dependent expression is in apparent contrast to the interpretation of other laboratories which have studied the expression of f-globin-DCR hypersensitive site 3 constructs (site II in their nomenclature) in transgenic mice (20, 25) . Those studies however, did not exclude the presence of mosaic mice. The presence of such mice in those analyses is further suggested by the use of transgenic fetuses at 16 days, which is relatively late in the adult globin expression stage, and will actually select for mosaics. Fully transgenic mice which express high levels of human ,3-globin do not survive if expression is not balanced by ct-globin expression (18, 19) . This probably explains why other laboratories have failed to find strict copy number dependent expression.
The expression level of human 13-globin in transgenic fetuses with high transgene copy numbers appears to occur in a noncopy number dependent manner. This is particularly obvious in fetuses 174 (site 1; 20-25 copies) and 354 (site 2; 40-50 copies). This phenomena was also observed by Curtin et al. (25) in site 3 transgenic fetuses with copy numbers greater than fourteen and in MEL cells containing high copy number transgenes (Talbot et al., unpubl.). We feel this may be due to physical limitations created by tandem integration of several small DCR constructs. High copy number transgenic fetuses which contain the full minilocus, which retains the normal spacing of the hypersensitive sites, still express ,B-globin in a copy number dependent manner suggesting that trans-acting factors are not limiting (15) . A more likely explanation is that the juxtaposition of several small DCR constructs creates an unusual chromatin structure which could extend for hundreds of kilobases, depending on the copy number. It is possible that such an artificial array of hypersensitive sites no longer allows each globin gene to be transcribed optimally.
An unexpected result from these experiments was the finding that at least the hypersensitive sites 1, 2 and 3 taken individually direct position independent expression from a linked globin gene. This apparent redundancy suggests that the sites may operate independently or have varied functional activities which are developmentally stage specific. This is suggested by the difference in activity found for site 1 constructs when assayed by transfection in adult type MEL cells (24) and the transgenic fetal liver. Mice containing a site 4 construct are active but only express at low levels and it is not clear whether it is independent of position of integration. This is in contrast to the in vivo results obtained in a patient with y,bo-thalassemia containing site 4 only in which the i-globin allele in cis is completely silent (33 
